Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability. (Q43779543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ian H. Gilbert

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

C Wolf

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

Maria Osuna-Cabello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Lesley A McLaughlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

6

Aileen W McLaren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Malcolm Taylor

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

479-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

22 February 2020

copyright license

start time

25 July 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Role of mammary epithelial and stromal P450 enzymes in the clearance and metabolic activation of 7,12-dimethylbenz(a)anthracene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

The murine Cyp1a1 gene is expressed in a restricted spatial and temporal pattern during embryonic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Mutagenicity, carcinogenicity and toxicity of beta-naphthoflavone, a potent inducer of P448.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Brca2 deficiency in the murine small intestine sensitizes to p53-dependent apoptosis and leads to the spontaneous deletion of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Lkb1 deficiency causes prostate neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Lkb1 deficiency alters goblet and paneth cell differentiation in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Loss of Indian Hedgehog activates multiple aspects of a wound healing response in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Intestinal label-retaining cells are secretory precursors expressing Lgr5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

A single type of progenitor cell maintains normal epidermis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

MBD2 deficiency does not accelerate p53 mediated lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140582

Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse

21 January 2018

1 reference

12 December 2020

Apc deficiency predisposes to renal carcinoma in the mouse

1 reference

12 December 2020

Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation.

1 reference

12 December 2020

Metabolism of styrene by mouse and rat isolated lung cells

1 reference

12 December 2020

Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics

1 reference

12 December 2020

The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity

1 reference

12 December 2020

Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes

1 reference

12 December 2020

Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system

1 reference

12 December 2020

Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice

1 reference

12 December 2020

Identifiers

DOI

10.1042/BJ20140582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25377919%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

25377919

1 reference